265 related articles for article (PubMed ID: 34470540)
1. Nuts and bolts of COVID-19 associated coagulopathy: the essentials for management and treatment.
Lindsay PJ; Rosovsky R; Bittner EA; Chang MG
Postgrad Med; 2021 Nov; 133(8):899-911. PubMed ID: 34470540
[TBL] [Abstract][Full Text] [Related]
2. Approach to the Patient with COVID-19-Associated Thrombosis: A Case-Based Review.
Chen EC; Zon RL; Battinelli EM; Connors JM
Oncologist; 2020 Oct; 25(10):e1500-e1508. PubMed ID: 32881209
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
Kreidieh F; Temraz S
Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
[TBL] [Abstract][Full Text] [Related]
4. Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19: implications for clinical practice and future investigations.
Flaczyk A; Rosovsky RP; Reed CT; Bankhead-Kendall BK; Bittner EA; Chang MG
Crit Care; 2020 Sep; 24(1):559. PubMed ID: 32938471
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 and thrombosis: From bench to bedside.
Ali MAM; Spinler SA
Trends Cardiovasc Med; 2021 Apr; 31(3):143-160. PubMed ID: 33338635
[TBL] [Abstract][Full Text] [Related]
6. [Coagulopathy and thrombosis: similarities and differences among pathogenic coronaviruses].
Páramo JA
An Sist Sanit Navar; 2020 Aug; 43(2):245-249. PubMed ID: 32814926
[TBL] [Abstract][Full Text] [Related]
7. Covid-19-induced coagulopathy and observed benefits with anticoagulation.
Karimzadeh S; Dong V; Hassan OG; Raut A; Fouda A; Parrill A; Eaton K; Huy NT
Transfus Apher Sci; 2020 Dec; 59(6):102906. PubMed ID: 32778522
[No Abstract] [Full Text] [Related]
8. COVID-19: coagulation disorders and anticoagulant treatment in patients hospitalised in ICU.
Pluta J; Cieniewicz A; Trzebicki J
Anaesthesiol Intensive Ther; 2021; 53(2):153-161. PubMed ID: 34006056
[TBL] [Abstract][Full Text] [Related]
9. Pragmatic Recommendations for the Management of Anticoagulation and Venous Thrombotic Disease for Hospitalized Patients with COVID-19 in Low- and Middle-Income Countries.
Ahmed HY; Papali A; Haile T; Shrestha GS; Schultz MJ; Lundeg G; Akrami KM;
Am J Trop Med Hyg; 2021 Jan; 104(3_Suppl):99-109. PubMed ID: 33432908
[TBL] [Abstract][Full Text] [Related]
10. Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19.
Dobesh PP; Trujillo TC
Pharmacotherapy; 2020 Nov; 40(11):1130-1151. PubMed ID: 33006163
[TBL] [Abstract][Full Text] [Related]
11. Physician experiences in management of COVID-19-associated coagulopathy in pregnancy: Communication from the ISTH SSC Subcommittee on Women's Health Issues in Thrombosis and Haemostasis.
Jevtic SD; Malinowski AK; Othman M; Abdul Kadir RA
J Thromb Haemost; 2021 Oct; 19(10):2539-2545. PubMed ID: 34260818
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management.
Manolis AS; Manolis TA; Manolis AA; Papatheou D; Melita H
J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):12-24. PubMed ID: 32924567
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week.
Farkouh ME; Stone GW; Lala A; Bagiella E; Moreno PR; Nadkarni GN; Ben-Yehuda O; Granada JF; Dressler O; Tinuoye EO; Granada C; Bustamante J; Peyra C; Godoy LC; Palacios IF; Fuster V
J Am Coll Cardiol; 2022 Mar; 79(9):917-928. PubMed ID: 35241226
[TBL] [Abstract][Full Text] [Related]
14. Thrombosis in COVID-19: A Narrative Review of Current Literature and Inpatient Management.
Hsu A; Ohnigian S; Chang A; Liu Y; Zayac AS; Olszewski AJ; Reagan JL
R I Med J (2013); 2021 Jun; 104(5):14-19. PubMed ID: 34044431
[TBL] [Abstract][Full Text] [Related]
15. Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy.
Al-Samkari H; Connors JM
Blood Adv; 2019 Nov; 3(22):3770-3779. PubMed ID: 31770442
[TBL] [Abstract][Full Text] [Related]
16. Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned?
Iba T; Levy JH; Maier CL; Connors JM; Levi M
J Thromb Haemost; 2024 Jun; 22(6):1541-1549. PubMed ID: 38428590
[TBL] [Abstract][Full Text] [Related]
17. [Guidelines for prophylaxis and anti-thrombotic treatment for patients with COVID-19. Consensus of the Latin American Cooperative Group on Hemostasis and Thrombosis (CLAHT)].
Guillermo-Esposito C; Casais P; Cesarman-Maus G; Andrade-Orsi F; Martínez-Rovira R; de-Campos-Guerra JC; Rezende SM; Izaguirre-Ávila R; Altman R; Ceresetto J; Colorio C; Duboscq C; Rosa CM; Molnar S; García D; Tejarina ML; García NN; Choque Pacheco J; J. María CC; Ramos Ramos G; León Basantes G; Milena Reyna A; Cantero Guevara M; Porres Aguilar M; Meillón L; Grimaldo FA; Bacon Fonseca LA; Ávila Milord A; Aguilar R; Aparicio R; de Guggiari P; Chumpitaz G; García PP; Steffano B; Damiano S; Serrano J; Zavahra M
Arch Cardiol Mex; 2021 Dec; 91(Suplemento COVID):047-054. PubMed ID: 33459726
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation in COVID-19: a review of current literature and guidelines.
Narasimhan B; Lorente-Ros M; Aguilar-Gallardo JS; Lizardo CP; Narasimhan H; Morton C; Donahue KR; Aronow WS
Hosp Pract (1995); 2021 Dec; 49(5):307-324. PubMed ID: 34807786
[TBL] [Abstract][Full Text] [Related]
19. AGA Clinical Practice Update: Coagulation in Cirrhosis.
O'Leary JG; Greenberg CS; Patton HM; Caldwell SH
Gastroenterology; 2019 Jul; 157(1):34-43.e1. PubMed ID: 30986390
[TBL] [Abstract][Full Text] [Related]
20. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.
Obi AT; Barnes GD; Napolitano LM; Henke PK; Wakefield TW
J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):23-35. PubMed ID: 32916371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
